Q BioMed Inc QBIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.02
- Bid/Ask
- $0.01 / $0.01
- Market Cap
- $43,528.36
- Volume/Avg
- 1,132 / 109,435
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Q BioMed Inc is a biomedical acceleration and development company. It has a focus on licensing, acquiring, and providing strategic resources to life sciences and healthcare companies. The company intends to mitigate risk by acquiring multiple assets over time and across a broad spectrum of healthcare-related products, companies, and sectors. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. It also has three development-stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 7
- Website
- https://www.qbiomed.com
Valuation
Metric
|
QBIO
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
QBIO
|
---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | 0.61 |
Quick Ratio
QBIO
Profitability
Metric
|
QBIO
|
---|---|
Return on Assets (Normalized) | −3.66% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
QBIO
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Lhglkrwph | Htql | $570.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xmsyzlht | Mkmrbc | $108.0 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Tjlyjvcst | Gsngqn | $105.6 Bil | |
MRNA
| Moderna Inc | Pnhgsbqy | Jpqsd | $40.8 Bil | |
ARGX
| argenx SE ADR | Kxtjqcf | Shhh | $23.5 Bil | |
BNTX
| BioNTech SE ADR | Hwlrjdj | Mpm | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zjgngcp | Jcfrn | $18.8 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xxmrhkn | Mqlwqss | $16.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Ztdglrhxwb | Brnstl | $13.6 Bil | |
INCY
| Incyte Corp | Kwfybdws | Lbvmbk | $12.8 Bil |